Erlonat

Erlonat is a generic drug, containing exactly the same active ingredients of Tarceva drug.
This drug is used to treat cases of non-small cell lung cancer, pancreatic cancer, and other cancers.
 
The drug is responsible for inhibiting the tyrosine receptor, which leads to tumors in the epidermis. The drug is marketed worldwide and is very well known in its field. It is often given along with chemotherapy, and according to studies, increases the survival rate of the disease.
 
For those suffering from various health problems, consult your doctor before using this medicine.
 
Erlonat is produced by Natco Pharma, one of the world's largest pharmaceutical companies.
The company, established in 1981, specializes in the research and development of drugs that provide therapeutic solutions to various medical problems.
 
The company has five manufacturing facilities in India as well as modern and innovative research laboratories, and has approved FDA drugs.
 
It is one of the leading competitors of Teva, which markets drugs throughout the developed world, including the European Union, and has a branch in Canada.